PT  - JOURNAL ARTICLE
AU  - J M S Bartlett
AU  - J Starczynski
AU  - Neil Atkey
AU  - E Kay
AU  - A O'Grady
AU  - Michael Gandy
AU  - Merdol Ibrahim
AU  - Bharat Jasani
AU  - I O Ellis
AU  - S E Pinder
AU  - R A Walker
TI  - HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods
AID  - 10.1136/jcp.2011.089847
DP  - 2011 Aug 01
TA  - Journal of Clinical Pathology
PG  - 649--653
VI  - 64
IP  - 8
4099  - http://jcp.bmj.com/content/64/8/649.short
4100  - http://jcp.bmj.com/content/64/8/649.full
SO  - J Clin Pathol2011 Aug 01; 64
AB  - These guidelines supplement existing guidelines on HER2 testing by immunohistochemistry and in-situ hybridisation(ISH) methods in the UK. They provide a specific focus on aspects of guidance relevant to HER2 ISH testing methods, both fluorescent and chromogenic. They are formulated to give advice on methodology, interpretation and quality control for ISH-based testing of HER2 status in common tumour types, including both breast and gastric tumours. The aim is to ensure that all ISH-based testing is accurate, reliable and timely.